Cancer Biomarkers Market Size, Share & Industry Analysis, By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, and Others), By Biomarker Type (PSA, HER-2, EGFR, KRAS, and Others), By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics, and Others), and Regional Forecast, 2019-2032

Last Updated: March 10, 2025 | Format: PDF | Report ID: FBI100630

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2015-2026
Base Year	2018
Forecast Period	2019-2026
Historical Period	2015-2017
Unit	Value (USD billion)
Segmentation	By Cancer Type Breast Cancer Lung Cancer Colorectal Cancer Prostate Cancer Others
	By Biomarker Type PSA HER-2 EGFR KRAS Others
	By End User Pharmaceutical & Biotechnology Companies Diagnostics & Research Laboratories Hospitals & Specialty Clinics Others
	By Geography North America (the U.S. and Canada) Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe) Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific) Latin America (Brazil, Mexico, and the Rest of Latin America) Middle East & Africa (South Africa, GCC and the Rest of Middle East & Africa)